(Q39881881)

15 September 2017

title

Narcotic antagonists in the treatment of opioid dependence: review and commentary (English)

1 reference

15 September 2017

Narcotic antagonists in the treatment of opioid dependence: Review and commentary (English)

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

28 April 2023

0 references

R. B. Resnick

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A421447

28 April 2023

E. Schuyten-Resnick

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A421447

28 April 2023

A. M. Washton

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A421447

28 April 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=421447

28 April 2023

publication date

1 March 1979

1 reference

full work available at URL

15 September 2017

https://api.elsevier.com/content/article/PII:0010440X79900427?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

https://api.elsevier.com/content/article/PII:0010440X79900427?httpAccept=text/plain

28 April 2023

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

28 April 2023

published in

Comprehensive Psychiatry

1 reference

15 September 2017

volume

20

1 reference

15 September 2017

issue

2

1 reference

15 September 2017

page(s)

116-125

1 reference

An experimental study in the treatment of narcotic addicts with cyclazocine

15 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

Dynamics of drug dependence. Implications of a conditioning theory for research and treatment.

28 April 2023

3

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

Cyclazocine and Methadone in Narcotic Addiction

28 April 2023

5

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

Clinical studies of cyclazocine in the treatment of narcotic addiction.

28 April 2023

6

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

Antagonism of the subjective, behavioral, pupillary, and respiratory depressant effects of cyclazocine by naloxone

28 April 2023

7

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

Cyclazocine treatment of opiate dependence: A progress report

28 April 2023

8

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

Naltrexone, an antagonist for the treatment of heroin dependence. Effects in man.

28 April 2023

10

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

Studies of EN-1639A (Naltrexone): A New Narcotic Antagonist

28 April 2023

11

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

Short-term effects of naltrexone in 155 heroin ex-addicts

28 April 2023

14

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

A Cyclazocine Typology in Opiate Dependence

28 April 2023

16

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

Varying clinical contexts for administering naltrexone

28 April 2023

18

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

Use of narcotic antagonists (naltrexone) in an addiction treatment program

28 April 2023

20

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

Clinical outcome with naltrexone

28 April 2023

22

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

The use of cyclazocine in treating narcotic addicts in a low-intervention setting

28 April 2023

27

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

Cyclazocine treatment for heroin addicts

28 April 2023

28

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

Interim report on clinic intake and safety data collected from 17 NIDA-funded naltrexone studies

28 April 2023

30

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

Opioid peptides (endorphins) in pituitary and brain

28 April 2023

32

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

The opiate receptor and morphine-like peptides in the brain

28 April 2023

33

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

Endorphins in psychiatry: an overview and a hypothesis

28 April 2023

34

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone

28 April 2023

36

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

Rapid detoxification of the narcotic addict with naloxone hydrochloride. A preliminary report

28 April 2023

38

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

Clonidine blocks acute opiate-withdrawal symptoms

28 April 2023

39

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

Clonidine hydrochloride: a nonopiate treatment for opiate withdrawal

28 April 2023

40

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

High-Dose Cyclazocine Therapy of Opiate Dependence

28 April 2023

41

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

A sustained release depot for narcotic antagonists.

28 April 2023

42

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

The development of sustained action preparations of narcotic antagonists

28 April 2023

43

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

Treatment of heroin dependence with opiate antagonists

28 April 2023

46

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

A controlled comparison of cyclazocine and naloxone treatment of the paroled narcotic addict

28 April 2023

49

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

Narcotic antagonists and the parolee—Outcome, issues, and new directions

28 April 2023

50

1 reference

https://api.crossref.org/works/10.1016/0010-440X(79)90042-7

28 April 2023

Identifiers

1 reference

15 September 2017

1 reference